D.E. Shaw & Co
MDT icon

D.E. Shaw & Co’s Medtronic MDT Stock Holding History

D.E. Shaw & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.5M Sell
894,615
-96,999
-10% -$9.29M 0.05% 476
2025
Q4 		$95.3M Sell
991,614
-61,186
-6% -$5.94M 0.05% 421
2025
Q3 		$100M Sell
1,052,800
-1,347,482
-56% -$124M 0.06% 393
2025
Q2 		$209M Buy
2,400,282
+223,901
+10% +$19M 0.15% 139
2025
Q1 		$196M Buy
2,176,381
+103,175
+5% +$9.23M 0.17% 126
2024
Q4 		$166M Buy
2,073,206
+1,719,432
+486% +$149M 0.12% 187
2024
Q3 		$31.9M Buy
353,774
+163,449
+86% +$13.8M 0.03% 723
2024
Q2 		$15M Sell
190,325
-193,551
-50% -$15.9M 0.01% 1070
2024
Q1 		$33.5M Buy
383,876
+170,862
+80% +$14.6M 0.03% 643
2023
Q4 		$17.5M Buy
213,014
+115,146
+118% +$8.78M 0.02% 1016
2023
Q3 		$7.67M Buy
97,868
+6,882
+8% +$576K 0.01% 1470
2023
Q2 		$8.02M Sell
90,986
-690,434
-88% -$59.4M 0.01% 1516
2023
Q1 		$63M Sell
781,420
-2,425,515
-76% -$198M 0.07% 352
2022
Q4 		$249M Buy
3,206,935
+1,424,203
+80% +$115M 0.28% 49
2022
Q3 		$144M Sell
1,782,732
-98,317
-5% -$8.84M 0.17% 96
2022
Q2 		$169M Sell
1,881,049
-56,875
-3% -$5.76M 0.2% 78
2022
Q1 		$215M Sell
1,937,924
-1,824,514
-48% -$193M 0.2% 79
2021
Q4 		$389M Buy
3,762,438
+2,509,590
+200% +$291M 0.32% 35
2021
Q3 		$157M Sell
1,252,848
-1,919,550
-61% -$248M 0.14% 140
2021
Q2 		$394M Sell
3,172,398
-608,574
-16% -$76.4M 0.34% 39
2021
Q1 		$447M Buy
3,780,972
+1,327,273
+54% +$156M 0.43% 24
2020
Q4 		$287M Sell
2,453,699
-57,936
-2% -$6.38M 0.26% 60
2020
Q3 		$261M Sell
2,511,635
-584,451
-19% -$58.7M 0.27% 57
2020
Q2 		$284M Buy
3,096,086
+1,287,775
+71% +$123M 0.34% 41
2020
Q1 		$163M Buy
1,808,311
+503,746
+39% +$53.6M 0.25% 70
2019
Q4 		$148M Sell
1,304,565
-590,042
-31% -$64.7M 0.17% 131
2019
Q3 		$206M Sell
1,894,607
-3,438,934
-64% -$359M 0.25% 62
2019
Q2 		$519M Buy
5,333,541
+927,269
+21% +$84.7M 0.65% 14
2019
Q1 		$401M Buy
4,406,272
+2,255,449
+105% +$202M 0.52% 23
2018
Q4 		$196M Buy
2,150,823
+1,523,109
+243% +$142M 0.27% 69
2018
Q3 		$61.7M Sell
627,714
-730,271
-54% -$67.5M 0.07% 328
2018
Q2 		$116M Sell
1,357,985
-2,030,836
-60% -$170M 0.15% 146
2018
Q1 		$272M Sell
3,388,821
-939,803
-22% -$77.5M 0.37% 46
2017
Q4 		$350M Buy
4,328,624
+2,802,318
+184% +$224M 0.48% 23
2017
Q3 		$119M Buy
1,526,306
+908,030
+147% +$75.4M 0.18% 127
2017
Q2 		$54.9M Sell
618,276
-1,490,779
-71% -$126M 0.09% 273
2017
Q1 		$170M Sell
2,109,055
-1,537,071
-42% -$120M 0.3% 62
2016
Q4 		$260M Buy
3,646,126
+3,445,093
+1,714% +$271M 0.44% 29
2016
Q3 		$17.4M Buy
+201,033
New +$17.5M 0.03% 632
2016
Q2 		– Sell
-342,192
Closed -$27.7M – 3450
2016
Q1 		$25.7M Sell
342,192
-201,572
-37% -$15.2M 0.05% 445
2015
Q4 		$41.8M Buy
543,764
+158,577
+41% +$11.9M 0.06% 365
2015
Q3 		$25.8M Sell
385,187
-33,988
-8% -$2.5M 0.04% 524
2015
Q2 		$31.1M Buy
419,175
+408,390
+3,787% +$31.2M 0.05% 473
2015
Q1 		$841K Buy
10,785
+453
+4% +$34.3K ﹤0.01% 2699
2014
Q4 		$746K Sell
10,332
-40,043
-79% -$2.78M ﹤0.01% 3054
2014
Q3 		$3.12M Buy
+50,375
New +$3.2M ﹤0.01% 1892
2014
Q2 		– Sell
-189,242
Closed -$11.5M – 4391
2014
Q1 		$11.6M Sell
189,242
-668,767
-78% -$39M 0.02% 959
2013
Q4 		$49.2M Buy
858,009
+665,114
+345% +$37.7M 0.07% 319
2013
Q3 		$10.3M Sell
192,895
-70,983
-27% -$3.82M 0.02% 980
2013
Q2 		$13.6M Buy
+263,878
New +$13M 0.03% 710

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's MDT Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Medtronic (MDT) stake by 9.8% in Q1 2026, selling an estimated $9.29M and leaving 894,615 shares worth $77.5M. The position accounts for 0.05% of the portfolio, ranked #476.

D.E. Shaw & Co first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $519M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • D.E. Shaw & Co held 894,615 shares of Medtronic worth $77.5M as of Q1 2026.
  • D.E. Shaw & Co sold 96,999 Medtronic shares in Q1 2026, an estimated $9.29M.
  • Medtronic made up 0.05% of D.E. Shaw & Co's portfolio in Q1 2026, its #476 holding.
  • D.E. Shaw & Co first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • D.E. Shaw & Co's Medtronic position peaked at $519M in Q2 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.